Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Allergy Prevalence in France and Skin Impact – Epidemiological S | CCID
2 Pfizer, FDA Delay Approval for Abrocitinib for Atopic Dermatitis
3 IgA epidermolysis bullosa acquisita may be more common than previously thought
4 100 metro doctors send letter to school districts urging universal masking
5 Summer is peak season for allergic diseases
6 How Bad Is It Really to Rarely Wash Your Sheets?
7 Looking at systemic treatment for atopic dermatitis
8 Atopic dermatitis and patient perspectives | JAA
9 Systemic Treatment for Pediatric AD
10 New molecule found in chestnut leaves disarms dangerous staph bacteria
11 Taskforce findings – Dermatology, Allergy and Immunology Clinical Committee report
12 Teledermatology in times of COVID‐19
13 Health: Pediatric Allergist Discusses Three Common Allergy Rashes & Their Triggers
14 Relieve your stress, relieve your allergies
15 Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry
16 Impact of COVID‐19 on wound care in Germany
17 Management of anaphylaxis due to COVID‐19 vaccines in the elderly
18 Corticotropin-releasing stress hormone may be linked to increased allergic reactions
19 Trial Finds Abrocitinib, Dupilumab Comparable for Atopic Dermatitis
20 $10 Million Gift to Open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai
21 Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
22 Forewarned is forearmed: chronic spontaneous urticaria as a potential risk to effective SARS‐CoV‐2 vaccine uptake and global public health
23 COVID‐19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID‐19 vaccines”
24 Drug retention not affected by adalimumab biosimilar switch
25 COVID‐19 pandemic and allergen immunotherapy – an EAACI survey
26 Last-itch effort: Fighting the bacteria that exacerbate eczema with bacteria
27 Q&A: TikTok's popularity could be beneficial to spread dermatology awareness
28 Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients
29 Low birth weight not associated with topical corticosteroid use in pregnancy
30 Novel immunotherapy approach to treat cat allergy
31 Seven Common Allergen Groups Causing Eyelid Dermatitis | OPTH
32 Increased occurrence of hand eczema in young children following the Danish hand hygiene recommendations during the COVID‐19 pandemic
33 Omalizumab Treatment for Urticarial Vasculitis | JAA
34 Increase in melanoma incidence likely multifactorial
35 What is a Dermatologist? What They Do, Conditions Treated, Procedures
36 Anti‐COVID‐19 measurements for hidradenitis suppurativa patients
37 MGH researchers call for greater awareness of delayed skin reactions after Moderna COVID-19 vaccine
38 A Patient's Guide to Skin Care | US News
39 Oral Medication Shows Strong Promise for Moderate to Severe Atopic Dermatitis in Mount Sinai-led Study
40 Mask‐induced Koebner phenomenon and its clinical phenotypes: A multicenter, real‐life study focusing on 873 dermatological consultations during COVID‐19 pandemics
41 Abrocitinib plus topical therapy effective in adolescents with atopic dermatitis
42 LEO Pharma Presents Data for Tralokinumab on Pooled Safety, S. aureus Colonization Reduction and Impact on Vaccine Response Rates at the 29th Annual European Academy of Dermatology and Venereology (EADV) Virtual Congress
43 Brand-Name Adalimumab for Psoriasis May Be Interchangeable with Biosimilars
44 Delayed cutaneous reaction to ChAdOx1 nCoV‐19 vaccine: Is it an 'AstraZeneca arm'?
45 Lay population stigmatizes patients with alopecia
46 ED visits may represent opportunity to de-label false penicillin allergies
47 Granuloma annulare more likely to affect white middle-aged women
48 Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccine
49 The impact of COVID‐19 pandemic on the management of patients with chronic urticaria: An observational two‐center study from Turkey
50 Skin reactions after COVID-19 vaccination: rare, uncommonly recur after second dose
51 Delayed cutaneous reaction to COVID-19 vaccine should not preclude further vaccinations
52 Managing AD Pain, Long-Term Therapy Effectively
53 Childhood AD shows small impact on educational attainment
54 Cutaneous immune-related adverse events often precede noncutaneous events
55 Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
56 Patients with psoriasis, skin of color experience disparities in identification, treatment
57 'Zoom dysmorphia' leads to increase in cosmetic consultations during COVID-19 pandemic
58 Roswell Park Comprehensive Cancer Center names dermatology chair
59 Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation
60 Nickel Allergic Contact Dermatitis: Identification, Treatment, and Prevention
61 LEO Pharma announces positive results of Phase 2b dose-finding study with delgocitinib cream in adult patients with mild-to-severe chronic hand eczema (CHE)
62 Health and wellbeing a top priority as students return to campus
63 The 7 Best Healthy Skin Tips From Dermatologists
64 Sweet syndrome induced by SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine
65 Article Skin Allergies: What Your Doctor Will Do
66 Impact of atopic dermatitis on learning
67 Broad spectrum of comorbidities may be common in children with atopic dermatitis
68 Most patients find tele-dermatology appointments suitable alternative to office visits
69 Telemedicine offers comparable visit satisfaction for patients with alopecia
70 Dermatology
71 New School Guidelines: How They Impact 504 Plans for Food Allergies
72 Biologics best other treatments in morbidity, mortality in generalized pustular psoriasis
73 Cough and rash: Causes, symptoms, treatment, and more
74 Hypersensitivity plays a role in late inflammatory reactions | CCID
75 Contact dermatitis: know the symptoms, treatment and causes
76 Skin barrier structures vary with race, ethnicity
77 Acute itching in eczema patients linked to environmental allergens
78 Reply to “Cabbage and COVID‐19”
79 Are you using antihistamines properly?
80 Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement
81 Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity
82 Poor match rates of osteopathic applicants into ACGME dermatology and other competitive specialties.
83 After COVID-19 vaccine, her skin bubbled and burned: One woman’s mysterious reaction
84 Dermatology Has a Problem With Skin Color
85 Dupixent does not hamper patch testing in atopic dermatitis
86 Cutaneous eruption in COVID‐19‐infected patients in Thailand: An observational descriptive study
87 Identifying and improving quality of care in AD
88 Understanding Autoimmune Diseases < Yale School of Medicine
89 High incidence of hand eczema in Danish schoolchildren following intensive hand hygiene during the COVID‐19 pandemic: a nationwide questionnaire study
90 Itch insight: Skin itch mechanisms differ on hairless versus hairy skin: Research breakthrough could inform different treatments for chronic skin itch sufferers
91 Contact urticaria caused by chlorhexidine in hydroalcoholic gel
92 Successful Dental Treatments Using Procaine Hydrochloride in a Patient | LRA
93 GEP tests show poor prognostic ability in recurrent stage I melanoma
94 Cutaneous adverse reactions after m‐RNA COVID‐19 vaccine: early reports from Northeast Italy
95 Patients Allergic to COVID Vax Got Dose 2 With Graded Dosing
96 Illinois, More States Weigh Elijah's Law for Food Allergy Kids in Preschools
97 Boston Doctor Explains Rare Cosmetic Filler Reactions to COVID Vaccine
98 NIH Launches Study of Allergic Reactions to COVID-19 Vaccines
99 Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2
100 Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid‐19 pandemic: A UK dermatology tertiary centre experience